I started Science Exchange because I saw how scientific research was evolving and becoming more specialized and multidisciplinary, which made collaborations inefficient.

I'm the founder and CEO of Science Exchange, a marketplace for scientific collaboration where researchers can order experiments from the world's best labs.

I'm Elizabeth Iorns, the founder and CEO of Science Exchange, and I have a background in cancer biology, having completed my PhD at the Institute of Cancer Research in London and a postdoc at the University of Miami before starting Science Exchange in 2011 as part of Y Combinator's summer batch.

The biggest challenge for Science Exchange when it started was convincing the conservative pharmaceutical industry to use the platform.

I'm Elizabeth Iorns, founder and CEO of Science Exchange, a marketplace for outsourced research and development, working with major pharmaceutical and science companies.

The decision to initiate the reproducibility initiative was a game-changer for Science Exchange, enhancing its branding and opening doors to pharmaceutical partnerships.

In a hundred years, Science Exchange will continue to enable scientific breakthroughs by providing infrastructure for collaboration among researchers.

Marketplaces like Science Exchange need to be the platform that companies use for all their projects, not just a one-off shopping experience, to be truly effective.

Science Exchange connects pharmaceutical companies with early-stage biotech firms, facilitating advancements in cancer biology and other areas. The application of artificial intelligence in the biological sector is leading to innovations in predicting drug efficacy and toxicity during the preclinical stage, which helps avoid clinical failures.